OBJECTIVES: Residual renal function (RRF) is of paramount importance to dialysis adequacy, morbidity, and mortality, particularly for long-term continuous ambulatory peritoneal dialysis (CAPD) patients. Residual renal function seems to be better preserved in patients on CAPD than in hemodialysis (HD) patients. We analyzed RRF in 45 patients with end-stage renal disease (ESRD), commencing either CAPD or HD, to prospectively define the time course of the decline in RRF, and to evaluate dialysis-technique-related factors such as cardiovascular stability and bioincompatibility. STUDY DESIGN: Single-center prospective investigation in parallel design with matched pairs. MATERIALS: Fifteen patients starting CAPD and 15 matched pairs of patients commencing HD were matched according to cause of renal failure and RRF. Hemodialysis patients were assigned to two dialyzer membranes differing markedly in their potential to activate complement and cells (bioincompatibility). Fifteen patients were treated exclusively with the cuprophane membrane (bioincompatible) and the other 15 patients received HD with the high-flux polysulfone membrane (biocompatible). MEASUREMENTS: Residual renal function was determined at initiation of dialytic therapy and after 6, 12, and 24 months. Dry weight (by chest x ray and diameter of the vena cava) was closely recorded throughout the study, and the number of hypotensive episodes counted. RESULTS: Residual renal function declined in both CAPD and HD patients, although this decline was faster in HD patients (2.8 mL/minute after 6 months and 3.7 mL/min after 12 months) than in CAPD patients (0.6 mL/min and 1.4 mL/min after 6 and 12 months respectively). It declined faster in patients with bioincompatible than with biocompatible HD membranes (3.6 mL/min vs 1.9 mL/min after 6 months). Eleven percent of the HD sessions were complicated by clinically relevant blood pressure reductions, but there were no differences between the two dialyzer membrane groups. None of the CAPD patients had documented hypotensive episodes. None of the study patients suffered severe illness or received nephrotoxic antibiotics or radiocontrast media. CONCLUSIONS: The better preservation of RRF in stable CAPD patients corresponded with greater cardiovascular stability compared to HD patients, independently of the membrane used. Furthermore, there was a significantly higher preservation of RRF in HD patients on polysulfone versus cuprophane membranes, indicating an additional effect of biocompatibility, such as less generation of nephrotoxic substances by the membrane. Thus, starting ESRD patients on HD prior to elective CAPD should be avoided for better preservation of RRF.

This article has been cited by other articles:

				B. Tokgoz CLINICAL ADVANTAGES OF PERITONEAL DIALYSIS Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S59 - S61. [Abstract] [Full Text] [PDF]

				P. Tam PERITONEAL DIALYSIS AND PRESERVATION OF RESIDUAL RENAL FUNCTION Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S108 - S110. [Abstract] [Full Text] [PDF]

				R. van den Berg, T. T. Cnossen, C. J. A. M. Konings, J. P. Kooman, F. M. van der Sande, and K. M. L. Leunissen Different treatment options in peritoneal dialysis NDT Plus, October 1, 2008; 1(suppl_4): iv14 - iv17. [Abstract] [Full Text] [PDF]

				B. Canaud Residual renal function: the delicate balance betweenbenefits and risks Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1801 - 1805. [Full Text] [PDF]

				O. Khawar, K. Kalantar-Zadeh, W. K. Lo, D. Johnson, and R. Mehrotra Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data? Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1317 - 1328. [Abstract] [Full Text] [PDF]

				S. Kuriyama PERITONEAL DIALYSIS IN PATIENTS WITH DIABETES: ARE THE BENEFITS GREATER THAN THE DISADVANTAGES? Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S190 - S195. [Abstract] [Full Text] [PDF]

				C. P. Lee, G. M. Chertow, and S. A. Zenios A Simulation Model to Estimate the Cost and Effectiveness of Alternative Dialysis Initiation Strategies Med Decis Making, September 1, 2006; 26(5): 535 - 549. [Abstract] [PDF]

				H. Schiffl, S. M. Lang, and R. Fischer Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients Nephrol. Dial. Transplant., October 1, 2002; 17(10): 1814 - 1818. [Abstract] [Full Text] [PDF]

Copyright © 2001 by Multimed Inc.